50. Lunsford K, Mackin A, Langston C, et al. Pharmacokinetics of the biological effects of subcutaneous enoxaparin in dogs (abst).
J Vet Intern Med 2005;19:400.
51. Lauer MA, Houghtaling PL, Peterson JG, et al. Attenuation of rebound ischemia after discontinuation of heparin therapy by
glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet
IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. Circulation 2001;104:2772-2777.
52. McMichael M. Primary hemostasis. J Vet Emerg Crit Care 2005;15:1-8.
53. Jang I-K, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 2005;111:2671-2683.
54. Abrams-Ogg, A, Mathews, KA. Acute immune-mediated hemolytic anemia in dogs. In: Mathews KA. Veterinary emergency and critical care manual. Guelph, Ontario: Lifelearn, 2006;411-415.
|
Featuring Information from:
